Clinical Trials
Showing 1-10 results of 14 total
Cancer
A Research Study of OBI-902 in Participants with Advanced Solid Tumors.
This study will evaluate the safety and tolerability of investigational drug OBI-902 in participants with advanced solid tumors. The study also aims to find...
Cancer
New study for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
This study will compare the medication Sonrotoclax plus an anti-CD20 antibody therapy versus Venetoclax plus Rituximab. Enrollment into the different study...
Cancer
New study for patients with HR+ HER2- advanced breast cancer
This is a double-blind, placebo-controlled study evaluating the efficacy and safety of Inavolisib + a CDK4/6 inhibitor and letrozole, versus placebo + a...
Cancer
New investigational drug for treatment of ovarian cancer
This study will test the safety and effectiveness of an investigational drug combined with an FDA approved dose of Bevacuzimab for ovarian cancer....
Cancer
Investigational drug for breast cancer patients with brain metastases
The purpose of this study is to evaluate the safety and effectiveness of investigational drug UTD1 in combination with approved capecitabine in the treatment...
Blood Disorders|Cancer
New investigational drug for Follicular Lymphoma
The purpose of this study is to see if the combination of the investigational drug epcoritamab with rituximab and lenalidomide has a better response rate and...
Cancer
Investigational drug for HER2-mutated/overexpressed/amplified cancer
This study is testing whether an investigational drug will help people with advanced cancers with HER2 alterations.
Cancer
New investigational drug for treatment of Myelofibrosis
This study will evaluate the safety and effectiveness of Navetemadlin combined with an FDA approved dose of Ruxolitinib. The purpose of this Phase III study...
Cancer|Neurology|Neurosurgery
New investigational drug for newly-diagnosed MGMT unmethylated glioblastoma
The goal of this Phase 3 clinical trial is to compare the effectiveness of niraparib versus temozolomide (TMZ) in adult participants with newly-diagnosed,...
Cancer|Women's Health
Investigational drug for treatment of Triple-Negative Breast Cancer
The purpose of this study is to evaluate the safety and effectiveness of investigational drug MK2870 in combination with other approved anti-cancer...